Skip to main content
. 2024 May 23;27(6):110096. doi: 10.1016/j.isci.2024.110096

TableĀ 2.

Number of samples contained in each of the melanoma ICB cohort

GEO ID Disease Treatment Pre (n) Post (n) Responder (n) Non-responder (n)
91061 Metastatic melanoma Anti PD-1 51 58 60 49
115821 Metastatic melanoma Anti PD-1 9 18 1 26
78220 Metastatic melanoma Anti PD-1 25 0 13 12
145996 Metastatic melanoma Anti PD-1 14 0 9 5
Total (n) 99 76 83 92